These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12570737)

  • 21. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using genomics to develop novel antibacterial therapeutics.
    Nagaraj NS; Singh OV
    Crit Rev Microbiol; 2010 Nov; 36(4):340-8. PubMed ID: 20670176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibacterial drug discovery--then, now and the genomics future.
    Monaghan RL; Barrett JF
    Biochem Pharmacol; 2006 Mar; 71(7):901-9. PubMed ID: 16494849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genomic approaches to antibacterial discovery.
    Payne DJ; Gwynn MN; Holmes DJ; Rosenberg M
    Methods Mol Biol; 2004; 266():231-59. PubMed ID: 15148422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
    Lu H; Tonge PJ
    Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of genomics in antibacterial target discovery.
    Buysse JM
    Curr Med Chem; 2001 Dec; 8(14):1713-26. PubMed ID: 11562290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microbial genomics and novel antibiotic discovery: new technology to search for new drugs.
    Dougherty TJ; Barrett JF; Pucci MJ
    Curr Pharm Des; 2002; 8(13):1119-35. PubMed ID: 12052223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomics in anti-infective drug discovery--getting to endgame.
    Haney SA; Alksne LE; Dunman PM; Murphy E; Projan SJ
    Curr Pharm Des; 2002; 8(13):1099-118. PubMed ID: 12052222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel targets for the future development of antibacterial agents.
    McDevitt D; Payne DJ; Holmes DJ; Rosenberg M
    J Appl Microbiol; 2002; 92 Suppl():28S-34S. PubMed ID: 12000610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The decline of antibiotic era--new approaches for antibacterial drug discovery.
    Jagusztyn-Krynicka EK; Wyszyńska A
    Pol J Microbiol; 2008; 57(2):91-8. PubMed ID: 18646395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peptide ligands in antibacterial drug discovery: use as inhibitors in target validation and target-based screening.
    Lapan KA; Chapple JP; Galcheva-Gargova Z; Yang M; Tao J
    Expert Opin Ther Targets; 2002 Aug; 6(4):507-16. PubMed ID: 12223065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibacterial drug discovery and structure-based design.
    Barker JJ
    Drug Discov Today; 2006 May; 11(9-10):391-404. PubMed ID: 16635801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Forecasting roles of combinatorial chemistry in the age of genomically derived drug discovery targets.
    Thorpe DS
    Comb Chem High Throughput Screen; 2000 Oct; 3(5):421-36. PubMed ID: 11032958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and characterization of potential drug targets by subtractive genome analyses of methicillin resistant Staphylococcus aureus.
    Uddin R; Saeed K
    Comput Biol Chem; 2014 Feb; 48():55-63. PubMed ID: 24361957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. From bacterial genomes to novel antibacterial agents: discovery, characterization, and antibacterial activity of compounds that bind to HI0065 (YjeE) from Haemophilus influenzae.
    Lerner CG; Hajduk PJ; Wagner R; Wagenaar FL; Woodall C; Gu YG; Searle XB; Florjancic AS; Zhang T; Clark RF; Cooper CS; Mack JC; Yu L; Cai M; Betz SF; Chovan LE; McCall JO; Black-Schaefer CL; Kakavas SJ; Schurdak ME; Comess KM; Walter KA; Edalji R; Dorwin SA; Smith RA; Hebert EJ; Harlan JE; Metzger RE; Merta PJ; Baranowski JL; Coen ML; Thornewell SJ; Shivakumar AG; Saiki AY; Soni N; Bui M; Balli DJ; Sanders WJ; Nilius AM; Holzman TF; Fesik SW; Beutel BA
    Chem Biol Drug Des; 2007 Jun; 69(6):395-404. PubMed ID: 17581233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progress in functional genomics approaches to antifungal drug target discovery.
    De Backer MD; Van Dijck P
    Trends Microbiol; 2003 Oct; 11(10):470-8. PubMed ID: 14557030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotic resistance in bacteria and its future for novel antibiotic development.
    Yoneyama H; Katsumata R
    Biosci Biotechnol Biochem; 2006 May; 70(5):1060-75. PubMed ID: 16717405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrated genomics and chemical biology herald an era of sophisticated antibacterial discovery, from defining essential genes to target elucidation.
    Warrier T; Romano KP; Clatworthy AE; Hung DT
    Cell Chem Biol; 2022 May; 29(5):716-729. PubMed ID: 35523184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties.
    Wang J; Kodali S; Lee SH; Galgoci A; Painter R; Dorso K; Racine F; Motyl M; Hernandez L; Tinney E; Colletti SL; Herath K; Cummings R; Salazar O; González I; Basilio A; Vicente F; Genilloud O; Pelaez F; Jayasuriya H; Young K; Cully DF; Singh SB
    Proc Natl Acad Sci U S A; 2007 May; 104(18):7612-6. PubMed ID: 17456595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.